Zeotech Limited (ASX:ZEO)
0.0720
0.00 (0.00%)
Apr 29, 2026, 3:06 PM AEST
Zeotech Revenue
Zeotech had revenue of 1.20M AUD in the half year ending December 31, 2025, with 65.07% growth. This brings the company's revenue in the last twelve months to 1.24M, up 26.93% year-over-year. In the fiscal year ending June 30, 2025, Zeotech had annual revenue of 966.09K with 24.64% growth.
Revenue (ttm)
1.24M
Revenue Growth
+26.93%
P/S Ratio
119.50
Revenue / Employee
n/a
Employees
n/a
Market Cap
148.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 966.09K | 190.97K | 24.64% |
| Jun 30, 2024 | 775.12K | -297.97K | -27.77% |
| Jun 30, 2023 | 1.07M | 427.45K | 66.21% |
| Jun 30, 2022 | 645.64K | 467.36K | 262.14% |
| Jun 30, 2021 | 178.29K | 178.03K | 68,471.54% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cygnus Metals | 592.40K |
| Encounter Resources | 74.15K |
| Ardea Resources | 3.98M |
| Quantum Graphite | 57.22K |
| Energy Transition Minerals | 587.00K |
| DevEx Resources | -72.45K |
| Resolution Minerals | 95.21K |
| Marmota | 32.61K |
Zeotech News
- 5 weeks ago - Zeotech Transcript: Investor update - Transcripts
- 6 months ago - Zeotech Transcript: Noosa Mining Investor Conference - Transcripts
- 9 months ago - Zeotech Transcript: Investor Update - Transcripts
- 9 months ago - Zeotech Transcript: Noosa Mining Investor Conference - Transcripts
- 10 months ago - Zeotech Transcript: Investor Update - Transcripts
- 1 year ago - Zeotech Transcript: Investor Update - Transcripts
- 1 year ago - Zeotech Earnings Call Transcript: Q2 2025 - Transcripts